跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ASPIFOX 5 MG/100 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ASPIFOX 5 MG/100 MG CAPSULAS DURAS
Approved
STANDARD
ASPIFOX 5 MG/100 MG CAPSULAS DURAS
Teva B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 7, 2020
Approval ID
bcb99b815202dfbd
Company
Teva B.V.
Type
Standard
Approval Details
Approval Id
bcb99b815202dfbd
Drug Cima Aemps Name
ASPIFOX 5 MG/100 MG CAPSULAS DURAS
Register Number
85382
Holder Company Name
Teva B.V.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-pharma-b-v
Authorization Date
2020-09-07
Dosage Form
CÁPSULA DURA
Dose
5 mg/100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Teva B.V.
Company Detail Path
/organization/teva-pharma-b-v
Company Information
Pharmaceutical Company Name
Teva Pharma B.V.
Country Name
Netherlands
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Website
http://www.tevapharm.com
Active Ingredients
ROSUVASTATINA CALCICA
5.20 mg
ACETILSALICILICO ACIDO
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 7, 2020
Approval ID
bcb99b815202dfbd
Type
Standard
Back to CIMA-AEMPS Approvals
